Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 1 |
2015 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.
Lancet. 2012 Jun 23;379(9834):2352-63. doi: 10.1016/S0140-6736(12)60768-5. Epub 2012 May 23.
Lancet. 2012.
PMID: 22632908
Free PMC article.
Clinical Trial.
Alteplase for acute ischemic stroke: outcomes by clinically important subgroups in the Third International Stroke Trial.
Lindley RI, Wardlaw JM, Whiteley WN, Cohen G, Blackwell L, Murray GD, Sandercock PA; IST-3 Collaborative Group.
Lindley RI, et al.
Stroke. 2015 Mar;46(3):746-56. doi: 10.1161/STROKEAHA.114.006573. Epub 2015 Jan 22.
Stroke. 2015.
PMID: 25613308
Clinical Trial.
Item in Clipboard
Cite
Cite